{"entity":{"type":"insider","cik":"0001763581","url":"/insider/0001763581","json_url":"/insider/0001763581.json","name":"Schoenberg Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":42,"first":"2019-03-07","last":"2026-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Schoenberg Mark","source":"filing","n_filings":42,"first_seen":"2019-03-07","last_seen":"2026-07-10"}],"transactions":[{"id":5916267,"accession":"0001437749-26-023290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-023290","line_url":"/filing/0001437749-26-023290#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":119763.0,"shares_owned_after_display":"119,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-10","scope":"insider"},{"id":5905870,"accession":"0001437749-26-021523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-021523","line_url":"/filing/0001437749-26-021523#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":350100.0,"total_display":"350,100.00","total_whole":"350,100","shares_owned_after":129763.0,"shares_owned_after_display":"129,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5980218,"accession":"0001437749-26-019964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-019964","line_url":"/filing/0001437749-26-019964#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5222.0,"shares_display":"5,222","price_per_share":27.3,"price_display":"27.30","price_state":"stated","total_value":142560.6,"total_display":"142,560.60","total_whole":"142,561","shares_owned_after":139763.0,"shares_owned_after_display":"139,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":6075491,"accession":"0001437749-26-016104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-016104","line_url":"/filing/0001437749-26-016104#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":134985.0,"shares_owned_after_display":"134,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider"},{"id":5777271,"accession":"0001437749-26-003040","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-26-003040","line_url":"/filing/0001437749-26-003040","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7373.0,"shares_display":"7,373","price_per_share":19.69,"price_display":"19.69","price_state":"stated","total_value":145174.37,"total_display":"145,174.37","total_whole":"145,174","shares_owned_after":144985.0,"shares_owned_after_display":"144,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider","n_lines":3},{"id":5137447,"accession":"0001437749-25-035821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-035821","line_url":"/filing/0001437749-25-035821#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":139025.0,"shares_owned_after_display":"139,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-20","scope":"insider"},{"id":4689557,"accession":"0001437749-25-028707","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-028707","line_url":"/filing/0001437749-25-028707#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":871.0,"shares_display":"871","price_per_share":19.11,"price_display":"19.11","price_state":"stated","total_value":16644.81,"total_display":"16,644.81","total_whole":"16,645","shares_owned_after":149025.0,"shares_owned_after_display":"149,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-09","scope":"insider"},{"id":5166635,"accession":"0001437749-25-026377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-026377","line_url":"/filing/0001437749-25-026377#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.69,"price_display":"17.69","price_state":"stated","total_value":176900.0,"total_display":"176,900.00","total_whole":"176,900","shares_owned_after":148229.0,"shares_owned_after_display":"148,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4646924,"accession":"0001437749-25-023961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-023961","line_url":"/filing/0001437749-25-023961#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5149.0,"shares_display":"5,149","price_per_share":19.14,"price_display":"19.14","price_state":"stated","total_value":98551.86,"total_display":"98,551.86","total_whole":"98,552","shares_owned_after":158229.0,"shares_owned_after_display":"158,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":4283301,"accession":"0001437749-25-020045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-020045","line_url":"/filing/0001437749-25-020045#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5162.0,"shares_display":"5,162","price_per_share":7.37,"price_display":"7.37","price_state":"stated","total_value":38043.94,"total_display":"38,043.94","total_whole":"38,044","shares_owned_after":153378.0,"shares_owned_after_display":"153,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider"},{"id":4564392,"accession":"0001437749-25-002688","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-25-002688","line_url":"/filing/0001437749-25-002688","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4551.0,"shares_display":"4,551","price_per_share":11.14,"price_display":"11.14","price_state":"stated","total_value":50698.14,"total_display":"50,698.14","total_whole":"50,698","shares_owned_after":148540.0,"shares_owned_after_display":"148,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider","n_lines":3},{"id":2398566,"accession":"0001437749-24-029040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-029040","line_url":"/filing/0001437749-24-029040#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":859.0,"shares_display":"859","price_per_share":13.08,"price_display":"13.08","price_state":"stated","total_value":11235.72,"total_display":"11,235.72","total_whole":"11,236","shares_owned_after":145091.0,"shares_owned_after_display":"145,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-12","scope":"insider"},{"id":2956282,"accession":"0001437749-24-019900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-019900","line_url":"/filing/0001437749-24-019900#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5153.0,"shares_display":"5,153","price_per_share":13.08,"price_display":"13.08","price_state":"stated","total_value":67401.24,"total_display":"67,401.24","total_whole":"67,401","shares_owned_after":144284.0,"shares_owned_after_display":"144,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2103430,"accession":"0001437749-24-008707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-008707","line_url":"/filing/0001437749-24-008707#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":14.05,"price_display":"14.05","price_state":"stated","total_value":168600.0,"total_display":"168,600.00","total_whole":"168,600","shares_owned_after":139437.0,"shares_owned_after_display":"139,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":9288355,"accession":"0001437749-24-003153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-003153","line_url":"/filing/0001437749-24-003153","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3789.0,"shares_display":"3,789","price_per_share":15.78,"price_display":"15.78","price_state":"stated","total_value":59790.42,"total_display":"59,790.42","total_whole":"59,790","shares_owned_after":149998.0,"shares_owned_after_display":"149,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider","n_lines":3},{"id":3056288,"accession":"0001437749-24-003016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-24-003016","line_url":"/filing/0001437749-24-003016","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3789.0,"shares_display":"3,789","price_per_share":15.74,"price_display":"15.74","price_state":"stated","total_value":59638.86,"total_display":"59,638.86","total_whole":"59,639","shares_owned_after":151437.0,"shares_owned_after_display":"151,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider","n_lines":3},{"id":8036092,"accession":"0001437749-23-002336","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-23-002336","line_url":"/filing/0001437749-23-002336","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":19228.0,"total_display":"19,228.00","total_whole":"19,228","shares_owned_after":147888.0,"shares_owned_after_display":"147,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider","n_lines":3},{"id":6653591,"accession":"0001437749-22-025549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-22-025549","line_url":"/filing/0001437749-22-025549#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258.0,"shares_display":"258","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":3057.3,"total_display":"3,057.30","total_whole":"3,057","shares_owned_after":23950.0,"shares_owned_after_display":"23,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6758525,"accession":"0001437749-22-021337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-22-021337","line_url":"/filing/0001437749-22-021337#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":259.0,"shares_display":"259","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":2022.79,"total_display":"2,022.79","total_whole":"2,023","shares_owned_after":23708.0,"shares_owned_after_display":"23,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-25","scope":"insider"},{"id":6683845,"accession":"0001437749-22-010701","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-22-010701","line_url":"/filing/0001437749-22-010701#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254.0,"shares_display":"254","price_per_share":6.62,"price_display":"6.62","price_state":"stated","total_value":1681.48,"total_display":"1,681.48","total_whole":"1,681","shares_owned_after":23467.0,"shares_owned_after_display":"23,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-30","filed_date":"2022-05-03","scope":"insider"},{"id":6622658,"accession":"0001209191-22-006384","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-006384","line_url":"/filing/0001209191-22-006384","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1374.0,"shares_display":"1,374","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":10414.92,"total_display":"10,414.92","total_whole":"10,415","shares_owned_after":23221.0,"shares_owned_after_display":"23,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider","n_lines":2},{"id":6976744,"accession":"0001209191-22-005416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-005416","line_url":"/filing/0001209191-22-005416#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":8.09,"price_display":"8.09","price_state":"stated","total_value":897.99,"total_display":"897.99","total_whole":"898","shares_owned_after":22095.0,"shares_owned_after_display":"22,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-26","filed_date":"2022-01-28","scope":"insider"},{"id":4105715,"accession":"0001209191-21-065756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065756","line_url":"/filing/0001209191-21-065756#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160.0,"shares_display":"160","price_per_share":13.1,"price_display":"13.10","price_state":"stated","total_value":2096.0,"total_display":"2,096.00","total_whole":"2,096","shares_owned_after":21997.0,"shares_owned_after_display":"21,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider"},{"id":4741661,"accession":"0001209191-21-062360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-062360","line_url":"/filing/0001209191-21-062360#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258.0,"shares_display":"258","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":4427.28,"total_display":"4,427.28","total_whole":"4,427","shares_owned_after":21837.0,"shares_owned_after_display":"21,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-02","scope":"insider"},{"id":5014926,"accession":"0001209191-21-061868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061868","line_url":"/filing/0001209191-21-061868#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":16.32,"price_display":"16.32","price_state":"stated","total_value":1746.24,"total_display":"1,746.24","total_whole":"1,746","shares_owned_after":21595.0,"shares_owned_after_display":"21,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-28","scope":"insider"},{"id":5529803,"accession":"0001209191-21-049477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-049477","line_url":"/filing/0001209191-21-049477#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":15.64,"price_display":"15.64","price_state":"stated","total_value":3800.52,"total_display":"3,800.52","total_whole":"3,801","shares_owned_after":21494.0,"shares_owned_after_display":"21,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":5046971,"accession":"0001209191-21-048398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048398","line_url":"/filing/0001209191-21-048398#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103.0,"shares_display":"103","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":1575.9,"total_display":"1,575.90","total_whole":"1,576","shares_owned_after":20821.0,"shares_owned_after_display":"20,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-28","scope":"insider"},{"id":5490689,"accession":"0001209191-21-029758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-029758","line_url":"/filing/0001209191-21-029758#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":4860.0,"total_display":"4,860.00","total_whole":"4,860","shares_owned_after":21132.0,"shares_owned_after_display":"21,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-05-04","scope":"insider"},{"id":4424091,"accession":"0001209191-21-028500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-028500","line_url":"/filing/0001209191-21-028500#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89.0,"shares_display":"89","price_per_share":19.63,"price_display":"19.63","price_state":"stated","total_value":1747.07,"total_display":"1,747.07","total_whole":"1,747","shares_owned_after":20875.0,"shares_owned_after_display":"20,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-27","scope":"insider"},{"id":4612155,"accession":"0001209191-21-006699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-006699","line_url":"/filing/0001209191-21-006699#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076.0,"shares_display":"1,076","price_per_share":22.07,"price_display":"22.07","price_state":"stated","total_value":23747.32,"total_display":"23,747.32","total_whole":"23,747","shares_owned_after":20755.0,"shares_owned_after_display":"20,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-31","filed_date":"2021-02-02","scope":"insider"},{"id":4612026,"accession":"0001209191-21-005460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-005460","line_url":"/filing/0001209191-21-005460#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":22.12,"price_display":"22.12","price_state":"stated","total_value":2212.0,"total_display":"2,212.00","total_whole":"2,212","shares_owned_after":19831.0,"shares_owned_after_display":"19,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-26","scope":"insider"},{"id":2193542,"accession":"0001209191-20-061921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-061921","line_url":"/filing/0001209191-20-061921#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":19.85,"price_display":"19.85","price_state":"stated","total_value":13140.7,"total_display":"13,140.70","total_whole":"13,141","shares_owned_after":19723.0,"shares_owned_after_display":"19,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-07","scope":"insider"},{"id":2912751,"accession":"0001209191-20-056066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-056066","line_url":"/filing/0001209191-20-056066#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":20.9461,"price_display":"20.95","price_state":"stated","total_value":2115.5561,"total_display":"2,115.56","total_whole":"2,116","shares_owned_after":19343.0,"shares_owned_after_display":"19,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-28","scope":"insider"},{"id":2512386,"accession":"0001209191-20-049741","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049741","line_url":"/filing/0001209191-20-049741#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":348.0,"shares_display":"348","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":7029.6,"total_display":"7,029.60","total_whole":"7,030","shares_owned_after":19236.0,"shares_owned_after_display":"19,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-08","scope":"insider"},{"id":2545586,"accession":"0001209191-20-043873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043873","line_url":"/filing/0001209191-20-043873#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":23.51,"price_display":"23.51","price_state":"stated","total_value":1645.7,"total_display":"1,645.70","total_whole":"1,646","shares_owned_after":18543.0,"shares_owned_after_display":"18,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-28","scope":"insider"},{"id":2470528,"accession":"0001209191-20-034672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-034672","line_url":"/filing/0001209191-20-034672#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":349.0,"shares_display":"349","price_per_share":27.5128,"price_display":"27.51","price_state":"stated","total_value":9601.9672,"total_display":"9,601.97","total_whole":"9,602","shares_owned_after":18404.0,"shares_owned_after_display":"18,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-05","scope":"insider"},{"id":2110243,"accession":"0001209191-20-025904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025904","line_url":"/filing/0001209191-20-025904#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":24.35,"price_display":"24.35","price_state":"stated","total_value":1704.5,"total_display":"1,704.50","total_whole":"1,705","shares_owned_after":17711.0,"shares_owned_after_display":"17,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-28","scope":"insider"},{"id":2224231,"accession":"0001209191-20-005200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-005200","line_url":"/filing/0001209191-20-005200#line-2","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322.0,"shares_display":"322","price_per_share":29.15,"price_display":"29.15","price_state":"stated","total_value":9386.3,"total_display":"9,386.30","total_whole":"9,386","shares_owned_after":9177.0,"shares_owned_after_display":"9,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-28","scope":"insider"},{"id":7980937,"accession":"0001209191-19-057692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-057692","line_url":"/filing/0001209191-19-057692#line-1","is_derivative":false,"issuer_cik":"0001668243","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001668243","owner_cik":"0001763581","owner_name":"Schoenberg Mark","owner_display_name":"Schoenberg Mark","owner_url":"/insider/0001763581","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1960.0,"shares_display":"1,960","price_per_share":28.17,"price_display":"28.17","price_state":"stated","total_value":55213.2,"total_display":"55,213.20","total_whole":"55,213","shares_owned_after":7967.0,"shares_owned_after_display":"7,967","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-21","scope":"insider"}],"collapsed":true,"next_cursor":"2019-11-19|7980937","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001668243","name":"UroGen Pharma Ltd.","url":"/issuer/0001668243","role":"Officer (Chief Medical Officer)","n_filings":42,"first_seen":"2019-03-07","last_seen":"2026-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001763581","retrieved_at":"2026-08-24T00:39:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}